Cargando…

Effectiveness of ChAdOx1 nCoV-19 vaccine during the delta (B.1.617.2) variant surge in India

Detalles Bibliográficos
Autores principales: Chakrabarti, Sasanka, Chakrabarti, Sankha Shubhra, Chandan, Gourav, Kaur, Upinder, Agrawal, Bimal Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942524/
https://www.ncbi.nlm.nih.gov/pubmed/35338863
http://dx.doi.org/10.1016/S1473-3099(22)00132-3
_version_ 1784673322590535680
author Chakrabarti, Sasanka
Chakrabarti, Sankha Shubhra
Chandan, Gourav
Kaur, Upinder
Agrawal, Bimal Kumar
author_facet Chakrabarti, Sasanka
Chakrabarti, Sankha Shubhra
Chandan, Gourav
Kaur, Upinder
Agrawal, Bimal Kumar
author_sort Chakrabarti, Sasanka
collection PubMed
description
format Online
Article
Text
id pubmed-8942524
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-89425242022-03-24 Effectiveness of ChAdOx1 nCoV-19 vaccine during the delta (B.1.617.2) variant surge in India Chakrabarti, Sasanka Chakrabarti, Sankha Shubhra Chandan, Gourav Kaur, Upinder Agrawal, Bimal Kumar Lancet Infect Dis Correspondence Elsevier Ltd. 2022-04 2022-03-23 /pmc/articles/PMC8942524/ /pubmed/35338863 http://dx.doi.org/10.1016/S1473-3099(22)00132-3 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Chakrabarti, Sasanka
Chakrabarti, Sankha Shubhra
Chandan, Gourav
Kaur, Upinder
Agrawal, Bimal Kumar
Effectiveness of ChAdOx1 nCoV-19 vaccine during the delta (B.1.617.2) variant surge in India
title Effectiveness of ChAdOx1 nCoV-19 vaccine during the delta (B.1.617.2) variant surge in India
title_full Effectiveness of ChAdOx1 nCoV-19 vaccine during the delta (B.1.617.2) variant surge in India
title_fullStr Effectiveness of ChAdOx1 nCoV-19 vaccine during the delta (B.1.617.2) variant surge in India
title_full_unstemmed Effectiveness of ChAdOx1 nCoV-19 vaccine during the delta (B.1.617.2) variant surge in India
title_short Effectiveness of ChAdOx1 nCoV-19 vaccine during the delta (B.1.617.2) variant surge in India
title_sort effectiveness of chadox1 ncov-19 vaccine during the delta (b.1.617.2) variant surge in india
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942524/
https://www.ncbi.nlm.nih.gov/pubmed/35338863
http://dx.doi.org/10.1016/S1473-3099(22)00132-3
work_keys_str_mv AT chakrabartisasanka effectivenessofchadox1ncov19vaccineduringthedeltab16172variantsurgeinindia
AT chakrabartisankhashubhra effectivenessofchadox1ncov19vaccineduringthedeltab16172variantsurgeinindia
AT chandangourav effectivenessofchadox1ncov19vaccineduringthedeltab16172variantsurgeinindia
AT kaurupinder effectivenessofchadox1ncov19vaccineduringthedeltab16172variantsurgeinindia
AT agrawalbimalkumar effectivenessofchadox1ncov19vaccineduringthedeltab16172variantsurgeinindia